These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18779624)

  • 21. Sweet's syndrome associated with granulocyte colony-stimulating factor.
    Jain KK
    Cutis; 1996 Feb; 57(2):107-10. PubMed ID: 8646854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte colony-stimulating factors and risk of acute myeloid leukemia and myelodysplastic syndrome.
    Lyman GH; Kuderer NM
    Cancer Treat Res; 2011; 157():167-78. PubMed ID: 21052956
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sweet's syndrome].
    Mizoguchi M
    Nihon Rinsho Meneki Gakkai Kaishi; 1996 Jun; 19(3):169-178. PubMed ID: 8963795
    [No Abstract]   [Full Text] [Related]  

  • 24. Neutrophilic panniculitis associated with myelodysplastic syndrome with abnormal nuclear forms.
    Becherer K; Golda N; Feldman M; Diaz-Arias A; Caldwell C
    J Cutan Pathol; 2009 Sep; 36(9):1024-6. PubMed ID: 19674208
    [No Abstract]   [Full Text] [Related]  

  • 25. Leukemic transformation in patients with myelodysplastic syndromes after treatment with granulocyte colony-stimulating factor.
    Diamantopoulos PT; Chatzileonida T; Galanopoulos A; Yiakoumis X; Saridaki AM; Angelidis A; Papakostas E; Bazanis E; Sachanas S; Michael M; Pangalis GA; Anagnostopoulos NI; Meletis J; Viniou NA
    Leuk Lymphoma; 2012 Oct; 53(10):2069-72. PubMed ID: 22360720
    [No Abstract]   [Full Text] [Related]  

  • 26. The Sweet syndrome or G-CSF reaction?
    Karp DL
    Ann Intern Med; 1992 Nov; 117(10):875-6. PubMed ID: 1384410
    [No Abstract]   [Full Text] [Related]  

  • 27. Against an aetiological role of G-CSF in neutrophilic dermatosis: a case report.
    Starobinski M; Masouyé I; Salomon D; Chapuis B
    Br J Haematol; 1997 Sep; 98(4):1049-50. PubMed ID: 9326211
    [No Abstract]   [Full Text] [Related]  

  • 28. Granulocyte colony-stimulating factor: key (f)actor or innocent bystander in the development of secondary myeloid malignancy?
    Touw IP; Bontenbal M
    J Natl Cancer Inst; 2007 Feb; 99(3):183-6. PubMed ID: 17284707
    [No Abstract]   [Full Text] [Related]  

  • 29. Splenic irradiation-induced Sweet's syndrome associated with preceding myelofibrosis.
    Che Y; Tanioka M; Matsumura Y; Miyachi Y
    Clin Exp Dermatol; 2008 Mar; 33(2):200-1. PubMed ID: 18021277
    [No Abstract]   [Full Text] [Related]  

  • 30. Favorable outcome of severe, extensive, granulocyte colony-stimulating factor-induced, corticosteroid-resistant Sweet's syndrome treated with high-dose intravenous immunoglobulin.
    Calixto R; Menezes Y; Ostronoff M; Sucupira A; Botelho LF; Florencio R; Martins M; Souto Maior AP
    J Clin Oncol; 2014 Feb; 32(5):e1-2. PubMed ID: 24395855
    [No Abstract]   [Full Text] [Related]  

  • 31. Chronic relapsing remitting Sweet syndrome--a harbinger of myelodysplastic syndrome.
    Kulasekararaj AG; Kordasti S; Basu T; Salisbury JR; Mufti GJ; du Vivier AW
    Br J Haematol; 2015 Sep; 170(5):649-56. PubMed ID: 25962438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sweet's syndrome secondary to granulocyte colony-stimulating factor.
    Prevost-Blank PL; Shwayder TA
    J Am Acad Dermatol; 1996 Dec; 35(6):995-7. PubMed ID: 8959967
    [No Abstract]   [Full Text] [Related]  

  • 33. Neutrophil-dependent cutaneous side-effects of leucocyte colony-stimulating factors: manifestations of a neutrophil recovery syndrome?
    Dereure O; Hillaire-Buys D; Guilhou JJ
    Br J Dermatol; 2004 Jun; 150(6):1228-30. PubMed ID: 15214930
    [No Abstract]   [Full Text] [Related]  

  • 34. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: double-edged swords.
    Wilson RF; Henry TD
    J Am Coll Cardiol; 2005 Nov; 46(9):1649-50. PubMed ID: 16256863
    [No Abstract]   [Full Text] [Related]  

  • 35. Myelodysplastic syndromes with monosomy 7 and granulocyte colony-stimulating factor.
    Yoshida Y
    Intern Med; 1995 Sep; 34(9):820-1. PubMed ID: 8580549
    [No Abstract]   [Full Text] [Related]  

  • 36. EPONYM. Sweet syndrome.
    Kim MJ; Choe YH
    Eur J Pediatr; 2010 Dec; 169(12):1439-44. PubMed ID: 20445990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphoedema-area-restricted Sweet syndrome during G-CSF treatment.
    Petit T; Frances C; Marinho E; Herson S; Chosidow O
    Lancet; 1996 Mar; 347(9002):690. PubMed ID: 8596402
    [No Abstract]   [Full Text] [Related]  

  • 38. Neutrophilic dermatoses with acute myeloid leukemia associated with an increase of serum colony-stimulating factor.
    Uhara H; Saida T; Nakazawa H; Ito T
    J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S10-2. PubMed ID: 18625369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Granulocyte colony-stimulating factor.
    Kaptan K; Beyan C; Ifran A
    CMAJ; 2006 Oct; 175(9):1095; author reply 1095-6. PubMed ID: 17060662
    [No Abstract]   [Full Text] [Related]  

  • 40. Leukocyte colony-stimulating factors. A review of associated neutrophilic dermatoses and vasculitides.
    Johnson ML; Grimwood RE
    Arch Dermatol; 1994 Jan; 130(1):77-81. PubMed ID: 7506900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.